UnknownNot Applicable

Thumb Basal Joint (CMC I) Arthritis - Preoperative Anxiety/Depression, Outcome Instruments, Carpal Cinematics and Cost-utility

Finland150 participantsStarted 2021-03-29

Plain-language summary

A project aiming to promote evidence based practice when treating thumb basal joint (CMC I) arthritis. We will aim to: 1) provide the minimal clinical difference of two general outcome instruments, 2) evaluate the association between pre-operative anxiety and/or depression and outcomes following trapeziectomy, 3) evaluate the effect of trapziectomy on carpal cinematics, 4) determine the cost-utility-ratio of trapeziectomy

Who can participate

Age range40 Years – 75 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Eaton-Glickel \>2 arhritis * Symptom duration \>3 months * Pain VAS \>30mm * No significant comorbidities, ASA I-II * Fluent in Finnish language Exclusion Criteria: * Eaton-Glickel \<2 * Duration of symptoms \<3 months * VAS \<30mm * ASA \>II * Inflammatory joint disease * Systemic corticosteroid or immunomodulatory medication * Upper limb symptoms not explained with CMC I artritis * Heavy smoking (\> 20 cigarettes per day) * Alcohol or drug abuse * Neurological condition affecting upper limb function * Other ipsilateral upper limb condition requiring surgery

What they're measuring

Patient-Rated Wrist Evaluation

Timeframe: 12 months

Michigan Hand Outcome Questionnaire

Timeframe: 12 months

Trial details

NCT IDNCT04826380

SponsorTöölö Hospital

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2024-04-01

Contact for this trial

Samuli Aspinen, M.D., Ph.D.

+358406360546 samuli.aspinen@hus.fi

View on ClinicalTrials.gov More Arthritis trials